@fightfarm36
Active 1 year, 6 months ago
Cancer immunotherapy is a promising approach for cancer therapy but is usually hindered by the inhibition of the tumor microenvironment (TME). Herein, we developed a cell membrane vehicle (CV) to co-deliver doxorubicin (Dox) and sorafenib (Sfn) as a drug delivery system (CV/D-S) to regulate the TME and sensitize the immunogenic cell death […] View
-
Langhoff Lester posted an update 1 year, 6 months ago
We found that
-5 cases detected and undetected by
-11 criteria were similar in demographics, comorbid mental disorders, service use, and impairment variables with the exception that cases detected by
-11 had a larger number of symptoms and were more likely to have probable drug dependence than undetected
-5 cases.
-5…[Read more]
-
Langhoff Lester became a registered member 1 year, 6 months ago
